|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's range||2.2500 - 2.2800|
|52-week range||1.5846 - 2.7491|
|Beta (5Y monthly)||0.45|
|PE ratio (TTM)||8.20|
|Forward dividend & yield||0.54 (23.10%)|
|Ex-dividend date||01 June 2021|
|1y target est||N/A|
Philip Morris (PM) secures more than 74% of Vectura's shares to become a majority stakeholder. The company expects to amplify growth in its Beyond Nicotine strategy via this move.
British inhaler developer Vectura has been barred from a major medical conference amid a growing backlash over its £1bn takeover by tobacco giant Philip Morris International.